26 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 26, 2022, 7:00 CET– ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its annual financial and operating results for the year ended December 31, 2021. The Company also provides a business update for Q1 2022.
13 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces Bryan, Garnier & Co, a leading investment bank focused on growth companies, has initiated research coverage with a buy rating and target price of EUR 17.00 per share. This is a 124% premium to the closing price of EUR 7.60 on April 12, 2022.
13 Apr 22
EINDHOVEN, the Netherlands & LAUSANNE, Switzerland—April 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces Lara Smith Weber will join the company as its Chief Financial Officer and Zouhir Mechta will join the company as its Vice President Operations

Upcoming Events

Recent Presentations